FREE NEJM E-TOC    HOME   |   SUBSCRIBE   |   CURRENT ISSUE   |   PAST ISSUES   |   COLLECTIONS   |   Search Term  Advanced Search

Sign in | Get NEJM's E-Mail Table of Contents — Free | Subscribe

Previous Volume 335:672-674 August 29, 1996 Number 9 Next

	Since this article has no abstract, we have provided an extract of the first 100 words of the full text and any section headings.

	Full Text Purchase this article Add to Personal Archive Add to Citation Manager Notify a Friend E-mail When Cited Related Article by Fazio, S. PubMed Citation

To the Editor: In their study of the use of growth hormone to treat dilated cardiomyopathy (March 28 issue),¹ Fazio et al. describe the beneficial effects of administering recombinant human growth hormone for three months and urge the planning of longer clinical trials to assess the effects of growth hormone in patients with this condition. We are concerned, however, that the levels of insulin-like growth factor I in the patients they describe were doubled and considerably above the normal range. This means that the patients had biochemical acromegaly, and it seems clear that in this instance growth hormone is being . . . [Full Text of this Article]

References

This article has been cited by other articles:

• Kaplan, R. C., McGinn, A. P., Pollak, M. N., Kuller, L. H., Strickler, H. D., Rohan, T. E., Cappola, A. R., Xue, X., Psaty, B. M. (2007). Association of Total Insulin-Like Growth Factor-I, Insulin-Like Growth Factor Binding Protein-1 (IGFBP-1), and IGFBP-3 Levels with Incident Coronary Events and Ischemic Stroke. J. Clin. Endocrinol. Metab. 92: 1319-1325 [Abstract] [Full Text]  
• Le Corvoisier, P., Hittinger, L., Chanson, P., Montagne, O., Macquin-Mavier, I., Maison, P. (2007). Cardiac Effects of Growth Hormone Treatment in Chronic Heart Failure: A Meta-Analysis. J. Clin. Endocrinol. Metab. 92: 180-185 [Abstract] [Full Text]  
• Osterziel, K. J., Blum, W. F., Strohm, O., Dietz, R. (2000). The Severity of Chronic Heart Failure due to Coronary Artery Disease Predicts the Endocrine Effects of Short- Term Growth Hormone Administration. J. Clin. Endocrinol. Metab. 85: 1533-1539 [Abstract] [Full Text]  
• Niebauer, J., Pflaum, C.-D., Clark, A. L., Strasburger, C. J., Hooper, J., Poole-Wilson, P. A., Coats, A. J. S., Anker, S. D. (1998). Deficient insulin-like growth factor I in chronic heart failure predicts altered body composition, anabolic deficiency, cytokine and neurohormonal activation. J Am Coll Cardiol 32: 393-397 [Abstract] [Full Text]  
• Dreifuss, P., Anker, S. D., Coats, A. J.S. (1998). Growth Hormone in Chronic Heart Failure • Response. Circulation 97: 1650-1651 [Full Text]